Avidity Biosciences Inc. (RNA)
NASDAQ: RNA
· Real-Time Price · USD
29.30
-0.02 (-0.07%)
At close: Jun 20, 2025, 3:59 PM
29.40
0.36%
After-hours: Jun 20, 2025, 07:24 PM EDT
-0.07% (1D)
| Bid | 29 |
| Market Cap | 3.53B |
| Revenue (ttm) | 8.93M |
| Net Income (ttm) | -369.22M |
| EPS (ttm) | -3 |
| PE Ratio (ttm) | -9.76 |
| Forward PE | -6.59 |
| Analyst | Buy |
| Ask | 29.94 |
| Volume | 791,673 |
| Avg. Volume (20D) | 1,573,072 |
| Open | 29.41 |
| Previous Close | 29.32 |
| Day's Range | 28.38 - 29.46 |
| 52-Week Range | 21.51 - 56.00 |
| Beta | 0.95 |
Analyst Forecast
According to 0 analyst ratings, the average rating for RNA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Avidity Biosciences Inc. is scheduled to release its earnings on Aug 8, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-18.65%
Shares of vaccine and gene therapy stocks are trad...
Unlock content with
Pro Subscription
3 months ago
+10.24%
Avidity Biosciences shares are trading higher after BMO Capital initiated coverage on the stock with an Outperform rating and anounced a $72 price target.
